行情

XON

XON

Intrexon
NASDAQ

实时行情|Nasdaq Last Sale

5.69
-0.19
-3.23%
盘后: 5.75 +0.06 +1.05% 16:11 12/13 EST
开盘
5.88
昨收
5.88
最高
5.96
最低
5.64
成交量
82.32万
成交额
--
52周最高
9.10
52周最低
3.950
市值
9.25亿
市盈率(TTM)
-1.5876
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

XON 新闻

  • 收盘:关注贸易关系进展 纳指标普创新高
  • 新浪美股.1小时前
  • 因为用了这三个词 “版权狂魔”迪士尼被告了
  • 新浪美股.2小时前
  • 美国众议院司法委员会投票通过特朗普弹劾指控
  • 新浪财经.2小时前
  • 英国豪车制造商阿斯顿马丁与投资者会谈 评估融资
  • 新浪美股.3小时前

更多

所属板块

生物技术和医学研究
-0.88%
制药与医学研究
-0.08%

热门股票

名称
价格
涨跌幅

XON 简况

Intrexon Corporation (Intrexon) forms collaborations to create biologically-based products and processes using synthetic biology. The Company's domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Belgium and Hungary. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components. The Company's synthetic biology capabilities include the ability to control the amount, location and modification of biological molecules to control the function and output of living cells and optimize for desired results at an industrial scale. The Company's technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabled Analysis and Processing (LEAP), and ActoBiotics platform.
展开

Webull提供Intrexon Corp的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。